Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting
- 1 April 2010
- journal article
- review article
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 91 (4) , 1143S-1147S
- https://doi.org/10.3945/ajcn.2010.28608e
Abstract
This article and others that focused on the clinical features, mechanisms, and epidemiology of skeletal muscle loss and wasting in chronic diseases,Keywords
This publication has 56 references indexed in Scilit:
- Selective androgen receptor modulators as function promoting therapiesCurrent Opinion in Clinical Nutrition and Metabolic Care, 2009
- Inflammatory burden and amino acid metabolism in cancer cachexiaCurrent Opinion in Clinical Nutrition and Metabolic Care, 2009
- Emergence of ghrelin as a treatment for cachexia syndromesNutrition, 2008
- Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover studyBritish Journal of Cancer, 2008
- Growth Hormone, Glutamine, and an Optimal Diet Reduces Parenteral Nutrition in Patients With Short Bowel SyndromeAnnals of Surgery, 2005
- Effects of Ghrelin Administration on Left Ventricular Function, Exercise Capacity, and Muscle Wasting in Patients With Chronic Heart FailureCirculation, 2004
- The Anabolic Androgenic Steroid Oxandrolone in the Treatment of Wasting and Catabolic DisordersDrugs, 2004
- Megestrol Acetate Stimulates Weight Gain and Ventilation in Underweight COPD PatientsChest, 2002
- Growth Hormone in the Treatment of Dilated CardiomyopathyNew England Journal of Medicine, 1996
- Anabolic Therapy with Growth Hormone Accelerates Protein Gain in Surgical Patients Requiring Nutritional RehabilitationAnnals of Surgery, 1993